Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
31.72
+1.05 (3.42%)
Mar 10, 2026, 2:24 PM CST
SHA:688180 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -1,281 | -2,283 | -2,386 | -720.91 | Upgrade
|
| Depreciation & Amortization | - | 298.65 | 315.4 | 293.65 | 248.98 | Upgrade
|
| Other Amortization | - | 28.42 | 17.12 | - | 15.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -12.78 | -29.41 | -27.01 | -0.81 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.94 | 0.52 | 9.03 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 71.23 | 75.19 | - | -65.75 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 71.03 | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 91.91 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -14.67 | 18.34 | 0.05 | 0.36 | Upgrade
|
| Other Operating Activities | - | -10.02 | -178.56 | -515.11 | 7.55 | Upgrade
|
| Change in Accounts Receivable | - | 54.21 | -314.42 | 971.48 | -770.56 | Upgrade
|
| Change in Inventory | - | -159.27 | -32.45 | -136.39 | -154.82 | Upgrade
|
| Change in Accounts Payable | - | -415.29 | 262.67 | -479.57 | 702.33 | Upgrade
|
| Change in Unearned Revenue | - | - | - | 1.05 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -10.67 | 19.01 | 330.62 | 195.05 | Upgrade
|
| Operating Cash Flow | - | -1,434 | -2,005 | -1,775 | -605.05 | Upgrade
|
| Capital Expenditures | - | -690.99 | -832.57 | -383.1 | -901.77 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.87 | 4.1 | 0 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | 2.22 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -10.85 | - | Upgrade
|
| Investment in Securities | - | -247.76 | -207.9 | -104.24 | -1,045 | Upgrade
|
| Other Investing Activities | - | 44.1 | 103.19 | 28.35 | 28.95 | Upgrade
|
| Investing Cash Flow | - | -892.78 | -933.19 | -467.62 | -1,918 | Upgrade
|
| Long-Term Debt Issued | - | 2,307 | 977.1 | 840.36 | 500 | Upgrade
|
| Long-Term Debt Repaid | - | -1,214 | -533.78 | -154.26 | -828.36 | Upgrade
|
| Net Debt Issued (Repaid) | - | 1,093 | 443.32 | 686.1 | -328.36 | Upgrade
|
| Issuance of Common Stock | - | - | 152.59 | 3,812 | 2,122 | Upgrade
|
| Repurchase of Common Stock | - | -4 | -26.89 | - | - | Upgrade
|
| Common Dividends Paid | - | -73.79 | -38.23 | - | -16.69 | Upgrade
|
| Other Financing Activities | - | 7.81 | 181.03 | 144.64 | 889 | Upgrade
|
| Financing Cash Flow | - | 1,023 | 711.83 | 4,643 | 2,666 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 12.01 | 7.55 | 92.27 | -23.23 | Upgrade
|
| Net Cash Flow | - | -1,291 | -2,219 | 2,492 | 119.61 | Upgrade
|
| Free Cash Flow | - | -2,125 | -2,838 | -2,158 | -1,507 | Upgrade
|
| Free Cash Flow Margin | - | -109.06% | -188.85% | -148.50% | -37.44% | Upgrade
|
| Free Cash Flow Per Share | - | -2.16 | -2.88 | -2.35 | -1.69 | Upgrade
|
| Cash Interest Paid | - | - | - | 25.55 | - | Upgrade
|
| Cash Income Tax Paid | - | 78.6 | -65.42 | 107.13 | -43.19 | Upgrade
|
| Levered Free Cash Flow | - | -1,104 | -2,116 | -1,310 | -1,174 | Upgrade
|
| Unlevered Free Cash Flow | - | -1,072 | -2,098 | -1,292 | -1,160 | Upgrade
|
| Change in Working Capital | - | -514.68 | 59.85 | 687.19 | -90.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.